Hyperfine, Inc. (HYPR) stock
HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3019% below fair value
$0.63−0.05 (-7.36%)
Close on Nov 13, 2026Market cap $66.74MP/E –Yield –
Hyperfine ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Hyperfine's ebitda for the twelve months ending Dec 31, 2022 was -$72.86M. For fiscal 2022 it was -$72.86M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$72.86M | – |
| FY2021 | Dec 31, 2021 | -$64.14M | – |
| FY2020 | Dec 31, 2020 | -$23.20M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$13.37M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.04M | – |
| Q2 FY2022 | Jun 30, 2022 | -$22.93M | – |
| Q1 FY2022 | Mar 31, 2022 | -$23.52M | – |
| Q4 FY2021 | Dec 31, 2021 | -$25.75M | – |
| Q3 FY2021 | Sep 30, 2021 | -$16.22M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.46M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.71M | – |
See a number that looks wrong?